Drug Type Small molecule drug |
Synonyms |
Target |
Action agonists |
Mechanism TLR1 agonists(toll like receptor 1 agonists), TLR2 agonists(Toll like receptor 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC17H9F2N3O4 |
InChIKeyWVIOJTZQQHDPIZ-UHFFFAOYSA-N |
CAS Registry3029403-05-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Discovery | China | 18 Mar 2024 |